Terms: = Prostate cancer AND ATP2B3, PMCA3, 492, ENSG00000067842
142 results:
1. Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era.
Das S; Luu M; Terris M; Klaassen Z; Kane CJ; Amling C; Cooperberg M; Rivera LG; Aronson W; Freedland SJ; Daskivich TJ
Urol Oncol; 2024 Jun; 42(6):175.e1-175.e8. PubMed ID: 38490923
[TBL] [Abstract] [Full Text] [Related]
2. Decision aids for people facing health treatment or screening decisions.
Stacey D; Lewis KB; Smith M; Carley M; Volk R; Douglas EE; Pacheco-Brousseau L; Finderup J; Gunderson J; Barry MJ; Bennett CL; Bravo P; Steffensen K; Gogovor A; Graham ID; Kelly SE; Légaré F; Sondergaard H; Thomson R; Trenaman L; Trevena L
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD001431. PubMed ID: 38284415
[TBL] [Abstract] [Full Text] [Related]
3. Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life.
Lebret T; Bonastre J; Fraslin A; Neuzillet Y; Droupy S; Rebillard X; Vordos D; Guy L; Villers A; Schneider M; Coloby P; Lacoste J; Méjean A; Lacoste J; Descotes JL; Eschwege P; Loison G; Blanché H; Mariani O; Ghaleh B; Mangin A; Sirab N; Groussard K; Radvanyi F; Allory Y; Benhamou S
BMJ Open; 2023 Dec; 13(12):e075942. PubMed ID: 38128940
[TBL] [Abstract] [Full Text] [Related]
4. Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis.
Di H; Wen Y
Prostate; 2024 Feb; 84(3):269-276. PubMed ID: 37905786
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic Syndrome is Associated with prostate cancer Diagnosed on Biopsy but not the Gleason Score and the Number of cancer-Positive Cores: A Prospective Controlled Study.
Bayraktar Z; Şahin C; Yıldırım S; Karaca Y; Sinanoğlu O
Arch Esp Urol; 2023 Sep; 76(7):504-510. PubMed ID: 37867335
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of treatment costs for primary localized prostate cancer in Austria and Vienna: an economic analysis.
Moll M; Goldner G
Front Public Health; 2023; 11():1016860. PubMed ID: 37325333
[TBL] [Abstract] [Full Text] [Related]
7. Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk prostate cancer: Results of a Phase III Multi-Institutional Trial.
Krauss DJ; Karrison T; Martinez AA; Morton G; Yan D; Bruner DW; Movsas B; Elshaikh M; Citrin D; Hershatter B; Michalski JM; Efstathiou JA; Currey A; Kavadi VS; Cury FL; Lock M; Raben A; Seaward SA; El-Gayed A; Rodgers JP; Sandler HM
J Clin Oncol; 2023 Jun; 41(17):3203-3216. PubMed ID: 37104748
[TBL] [Abstract] [Full Text] [Related]
8. African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043366
[TBL] [Abstract] [Full Text] [Related]
9. The effect of the da Vinci
Pellegrino F; Tin AL; Sjoberg DD; Benfante NE; Weber RC; Porwal SP; Briganti A; Montorsi F; Eastham JA; Laudone VP; Vickers AJ
J Robot Surg; 2023 Aug; 17(4):1763-1768. PubMed ID: 37043122
[TBL] [Abstract] [Full Text] [Related]
10. Serum metabolomic profile of hair dye use.
Lim JE; Huang J; Weinstein SJ; Parisi D; Mӓnnistö S; Albanes D
Sci Rep; 2023 Mar; 13(1):3776. PubMed ID: 36882504
[TBL] [Abstract] [Full Text] [Related]
11. ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical prostatectomy With Positive Surgical Margins.
Salles DC; Mendes AA; Han M; Partin AW; Trock BJ; Jing Y; Lotan TL
Mod Pathol; 2023 Jul; 36(7):100147. PubMed ID: 36828362
[TBL] [Abstract] [Full Text] [Related]
12. Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.
Alshalalfa M; Nguyen TT; Stopsack KH; Khan A; Franco I; Seldon C; Swami N; Jin W; Meiyappan K; Ton M; Venstrom JM; Dee EC; Mahal BA
Urol Oncol; 2023 Feb; 41(2):106.e17-106.e23. PubMed ID: 36400666
[TBL] [Abstract] [Full Text] [Related]
13. Systematic Review and Meta-Analysis of Free-Hand and Fixed-Arm Spatial Tracking Methodologies in Software-Guided MRI-TRUS Fusion prostate Biopsy Platforms.
Zhao CC; Rossi JK; Wysock JS
Urology; 2023 Jan; 171():16-22. PubMed ID: 36243143
[TBL] [Abstract] [Full Text] [Related]
14. Association between prior cancer diagnosis and osteoporosis: a matched case-control study.
Yang S; Wang N; Wang J; Lix LM; Leslie WD; Yuan B
Arch Osteoporos; 2022 Aug; 17(1):112. PubMed ID: 35960383
[TBL] [Abstract] [Full Text] [Related]
15. Role of Serum Creatinine Levels in Prognostic Risk Stratification of prostate cancer Patients.
Gu X; Wu J; Liu X; Hong Y; Wu Y; Tian Y
Med Sci Monit; 2022 Jul; 28():e937100. PubMed ID: 35864726
[TBL] [Abstract] [Full Text] [Related]
16. Can we use Ki67 expression to predict prostate cancer aggressiveness?
Maia R; Santos GAD; Reis S; Viana NI; Pimenta R; Guimarães VR; Recuero S; Romão P; Leite KRM; Srougi M; Passerotti CC
Rev Col Bras Cir; 2022; 49():e20223200. PubMed ID: 35792806
[TBL] [Abstract] [Full Text] [Related]
17. Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors.
Katz AJ; Chen RC; Usinger DS; Danus SM; Zullig LL
J Cancer Surviv; 2023 Apr; 17(2):351-359. PubMed ID: 35790675
[TBL] [Abstract] [Full Text] [Related]
18. Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.
Saad F; Efstathiou E; Attard G; Flaig TW; Franke F; Goodman OB; Oudard S; Steuber T; Suzuki H; Wu D; Yeruva K; De Porre P; Brookman-May S; Li S; Li J; Thomas S; Bevans KB; Mundle SD; McCarthy SA; Rathkopf DE;
Lancet Oncol; 2021 Nov; 22(11):1541-1559. PubMed ID: 34600602
[TBL] [Abstract] [Full Text] [Related]
19. Biodistribution and internal radiation dosimetry of a companion diagnostic radiopharmaceutical, [
Kim SB; Song IH; Song YS; Lee BC; Gupta A; Lee JS; Park HS; Kim SE
Sci Rep; 2021 Jul; 11(1):15263. PubMed ID: 34315965
[TBL] [Abstract] [Full Text] [Related]
20. Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer.
Kourbanhoussen K; Joncas FH; D Wallis CJ; Hovington H; Dagenais F; Fradet Y; Guillemette C; Lacombe L; Toren P
Asian J Androl; 2022; 24(1):21-25. PubMed ID: 34259197
[TBL] [Abstract] [Full Text] [Related]
[Next]
